The Food and Drug Administration (FDA) has approved Journavx™ (suzetrigine) for the treatment of moderate to severe acute pain in adults.
Oral semaglutide administered via the RaniPill® HC (RT-116) demonstrated comparable bioavailability, pharmacokinetics and ...
News Medical on MSN23h
New study reveals how anticancer drugs enter cancer cellsA new study shows how an anticancer drug triggers an "outside in" signal that gets it sucked into a cancer cell.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback